Working with Partners to Support Late-Stage Clinical Trials
Learn about how FUJIFILM Biotechnologies works with partners to support late stage clinical trials with titer, host cell proteins and scalability.
De‑Risking Biotherapeutic Administration via CDMO‑Led Clinical‑Mimic and In‑Use Testing Strategies
Webinar discussing how to de-risk biotherapeutic administration via CDMO-led clinical mimic studies.
Viral Vector Manufacturing Simplified: A Sponsor’s Guide to Smarter CDMO Partnerships
Discover how to simplify viral vector manufacturing with smarter CDMO partnerships - align on process, balance cost/quality/speed, and accelerate to GMP.
March 2026 Newsletter
Read up on FUJIFILM Biotechnologies' March 2026 Special Edition of the IN FOCUS Newsletter.
How Flexible Single-Use Manufacturing Ecosystems Are Redefining Speed, Scale, and Sustainability in Biologics Production
SME spotlight video highlighting how single-use biomanufacturing ecosystems can support speed, flexibility and scale.
MaruX™ Raises the Bar on What’s Achievable in Continuous Manufacturing
MaruX by FUJIFILM Biotechnologies: automated continuous biomanufacturing integrating perfusion bioreactors and SymphonX to give proven results
How Biopharma Leaders are Redefining Partnership Across the Lifecycle
Leaders from J&J, Regeneron, Jacobs and FUJIFILM Biotechnologies share how partnerships reduce risk, scale programs, and accelerate therapies to patients.
Outsourced Pharma Capacity Update – Large Molecule, March 2026
Catch up on FUJIFILM Biotechnologies' large molecule capacity update webinar from March 2026, presented by Mark Santos.
Accelerating and Streamlining Microbial Process Development with ShunzymeX™
Watch this webinar to learn about the development and production of ShunzymeX™ and how it can accelerate and streamline microbial process development.
Data-Driven and Cellular Kinetics Approach to Mammalian Scale-up and Transfer
Learn more about how FUJIFILM Biotechnologies supports partners by employing an integrated model-based scale-up and transfer strategy.